PL3033327T3 - Sól (l)-(+)-winianowa (-)-(2r,3s)-2-amino-3-hydroksy-3-pirydyn-4-ylo-1-pirolidyn-1-ylo-propan-1-onu, sposoby jej produkcji i użycia - Google Patents
Sól (l)-(+)-winianowa (-)-(2r,3s)-2-amino-3-hydroksy-3-pirydyn-4-ylo-1-pirolidyn-1-ylo-propan-1-onu, sposoby jej produkcji i użyciaInfo
- Publication number
- PL3033327T3 PL3033327T3 PL14755535T PL14755535T PL3033327T3 PL 3033327 T3 PL3033327 T3 PL 3033327T3 PL 14755535 T PL14755535 T PL 14755535T PL 14755535 T PL14755535 T PL 14755535T PL 3033327 T3 PL3033327 T3 PL 3033327T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrrolidin
- propan
- pyridin
- hydroxy
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361866155P | 2013-08-15 | 2013-08-15 | |
EP14755535.3A EP3033327B1 (en) | 2013-08-15 | 2014-08-14 | (-)-(2r,3s)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (l)-(+) tartrate salt, its method of production and use |
PCT/US2014/051007 WO2015023816A1 (en) | 2013-08-15 | 2014-08-14 | (-)-(2r,3s)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (l)-(+) tartrate salt, its method of production and use |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3033327T3 true PL3033327T3 (pl) | 2018-07-31 |
Family
ID=51398940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14755535T PL3033327T3 (pl) | 2013-08-15 | 2014-08-14 | Sól (l)-(+)-winianowa (-)-(2r,3s)-2-amino-3-hydroksy-3-pirydyn-4-ylo-1-pirolidyn-1-ylo-propan-1-onu, sposoby jej produkcji i użycia |
Country Status (14)
Country | Link |
---|---|
US (2) | US9242935B2 (pl) |
EP (2) | EP3033327B1 (pl) |
JP (1) | JP6486358B2 (pl) |
CN (2) | CN105555765B (pl) |
CA (1) | CA2921385C (pl) |
DK (1) | DK3033327T3 (pl) |
ES (1) | ES2664749T3 (pl) |
HK (1) | HK1224292A1 (pl) |
HU (1) | HUE036381T2 (pl) |
NO (1) | NO2960430T3 (pl) |
PL (1) | PL3033327T3 (pl) |
PT (1) | PT3033327T (pl) |
SI (1) | SI3033327T1 (pl) |
WO (1) | WO2015023816A1 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9242935B2 (en) | 2013-08-15 | 2016-01-26 | Allergan, Inc. | (-)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt, its method of production and use |
US9992703B2 (en) * | 2016-04-04 | 2018-06-05 | Cisco Technology, Inc. | Insertion of management packet into a deterministic track |
WO2023154450A2 (en) * | 2022-02-11 | 2023-08-17 | Gilgamesh Pharmaceuticals, Inc. | (ampa-pam)-nmda receptor antagonist combination therapy for treatment of mental conditions and disorders |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5545745A (en) * | 1994-05-23 | 1996-08-13 | Sepracor, Inc. | Enantioselective preparation of optically pure albuterol |
US6835831B2 (en) * | 2001-11-26 | 2004-12-28 | Genzyme Corporation | Diastereoselective synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
HUE028654T2 (en) * | 2005-01-26 | 2016-12-28 | Allergan Inc | 3-aryl-3-hydroxy-2-aminopropionic amides, 3-heteroaryl-3-hydroxy-2-aminopropionic amides and related compounds having analgesic and / or immunostimulating activity |
WO2008011478A2 (en) * | 2006-07-19 | 2008-01-24 | Allergan, Inc. | Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds |
WO2008011483A2 (en) * | 2006-07-19 | 2008-01-24 | Allergan, Inc. | Methods for treating chronic pain using 1- (hetero) aryl-1-hydroxy 2,3-diamino-propyl amines and related compounds |
US8173683B2 (en) * | 2007-03-06 | 2012-05-08 | Allergan, Inc. | Methods for treating cognitive disorders |
WO2008109286A1 (en) * | 2007-03-06 | 2008-09-12 | Allergan, Inc. | Methods for treating cognitive disorders using 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds |
TR201818771T4 (tr) * | 2007-03-06 | 2019-01-21 | Allergan Inc | Bilişsel Bozuklukların Tedavisinde Kullanıma Yönelik Bileşikler |
US9242935B2 (en) | 2013-08-15 | 2016-01-26 | Allergan, Inc. | (-)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt, its method of production and use |
-
2014
- 2014-08-14 US US14/459,551 patent/US9242935B2/en active Active
- 2014-08-14 CN CN201480050583.7A patent/CN105555765B/zh active Active
- 2014-08-14 PL PL14755535T patent/PL3033327T3/pl unknown
- 2014-08-14 ES ES14755535.3T patent/ES2664749T3/es active Active
- 2014-08-14 JP JP2016534827A patent/JP6486358B2/ja active Active
- 2014-08-14 HU HUE14755535A patent/HUE036381T2/hu unknown
- 2014-08-14 EP EP14755535.3A patent/EP3033327B1/en active Active
- 2014-08-14 DK DK14755535.3T patent/DK3033327T3/en active
- 2014-08-14 EP EP18150038.0A patent/EP3336079A1/en not_active Withdrawn
- 2014-08-14 CN CN201810276093.9A patent/CN108794386B/zh active Active
- 2014-08-14 WO PCT/US2014/051007 patent/WO2015023816A1/en active Application Filing
- 2014-08-14 SI SI201430670T patent/SI3033327T1/en unknown
- 2014-08-14 PT PT147555353T patent/PT3033327T/pt unknown
- 2014-08-14 CA CA2921385A patent/CA2921385C/en active Active
-
2015
- 2015-06-26 NO NO15174003A patent/NO2960430T3/no unknown
- 2015-12-21 US US14/976,926 patent/US9540328B2/en active Active
-
2016
- 2016-11-03 HK HK16112633.0A patent/HK1224292A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2921385A1 (en) | 2015-02-19 |
HK1224292A1 (zh) | 2017-08-18 |
CN105555765A (zh) | 2016-05-04 |
CN108794386B (zh) | 2021-06-22 |
US20160347712A1 (en) | 2016-12-01 |
EP3033327B1 (en) | 2018-01-03 |
EP3033327A1 (en) | 2016-06-22 |
DK3033327T3 (en) | 2018-04-16 |
CA2921385C (en) | 2021-10-19 |
HUE036381T2 (hu) | 2018-07-30 |
US9540328B2 (en) | 2017-01-10 |
US20150051253A1 (en) | 2015-02-19 |
JP2016528255A (ja) | 2016-09-15 |
NO2960430T3 (pl) | 2018-01-06 |
EP3336079A1 (en) | 2018-06-20 |
ES2664749T3 (es) | 2018-04-23 |
CN105555765B (zh) | 2018-05-25 |
PT3033327T (pt) | 2018-04-04 |
CN108794386A (zh) | 2018-11-13 |
US9242935B2 (en) | 2016-01-26 |
JP6486358B2 (ja) | 2019-03-20 |
SI3033327T1 (en) | 2018-05-31 |
WO2015023816A1 (en) | 2015-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20170888T1 (hr) | Spoj tubulisina, metode pripreme i primjena | |
EP2997837A4 (en) | Disintegrable capsule, manufacturing method for same, and smoking equipment containing said disintegrable capsule | |
HK1209324A1 (en) | Nanozymes, methods of making nanozymes, and methods of using nanozymes | |
EP3031777A4 (en) | ZEOLITE AND PROCESS FOR PRODUCTION AND USE THEREFOR | |
HK1205650A1 (en) | Brassiere cup, brassiere, and brassiere production method | |
HK1225993A1 (zh) | 糖胺聚糖的化合物、其製備方法及用途 | |
EP2949639A4 (en) | PREPARATION FOR ALPHA, ALPHA-DIFLUORACETALDEHYDE | |
EP3079679A4 (en) | Method of treatment of alopecia with monoterpenoids | |
HK1224292A1 (zh) | -氨基- -羥基- -吡啶- -基- -吡咯烷- -基-丙- -酮 酒石酸鹽、其製備方法及用途 | |
PL3055679T3 (pl) | Środek do wykrywania pęknięć, sposób jego wytwarzania i zastosowanie środka do wykrywania pęknięć | |
GB2516425B (en) | Encoder and decoder, and method of operation | |
GB201413583D0 (en) | Desiccant cap and method of production and use | |
IL241096B (en) | Treatment methods | |
ZA201503410B (en) | Method of making alpha, omega-diiodoperfluoroalkanes | |
ZA201603990B (en) | Taxane compound, and preparation method and use thereof | |
ZA201603682B (en) | Taxanes compounds, preparation method therefor, and uses thereof | |
IL245018A (en) | A synthetic intermediate of maxaccalitol, a method for its preparation and use | |
EP2963020A4 (en) | NOVEL CONNECTION, MANUFACTURING METHOD AND USE OF THE SAID CONNECTION | |
PL2848608T3 (pl) | Związki kompleksowe srebra, sposób wytwarzania związków oraz zastosowanie związków | |
AU2013904712A0 (en) | Method of Treatment | |
AU2013904170A0 (en) | Method of treatment | |
GB201322778D0 (en) | Method of treatment | |
AU2013901359A0 (en) | Methods of Treatment | |
GB201314882D0 (en) | Method of treatment | |
AU2013902599A0 (en) | Treatment method |